The Latest in Hematology Times

Cancer patients prefer computer-free interactions

November 3, 2017

BCMA emerging as a promising target in MM

November 2, 2017

Multiple Myeloma

Study reveals misperceptions among AML patients

November 2, 2017

Drug receives fast track designation for lower-risk MDS

November 2, 2017

FDA approves drug to treat rel/ref MCL

November 1, 2017

Speaker advises caution in adding mAbs upfront in MM

November 1, 2017

Multiple Myeloma

FDA to rely on foreign authorities’ inspections

November 1, 2017

X-GEM finds drug to have economic value in MM

October 31, 2017

Multiple Myeloma

Ibrutinib approved to treat cGVHD in Canada

October 31, 2017

FDA approves lower dose of rivaroxaban

October 31, 2017

Protein may be therapeutic target for MM

October 30, 2017

Multiple Myeloma

Therapy receives rare pediatric disease designation

October 29, 2017

Gene therapy granted breakthrough designation

October 28, 2017

Thrombosis

Targeting key pathways to eradicate AML

October 27, 2017

FDA approves IV formulation of drug for CINV

October 27, 2017